1Groupe DE, Group D'Etude Et De,et al. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med, 1995, 332:1256
2Yan AP, Lin G, Zhou HY,et al. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer. Cancer, 1993, 72:3210
3Mantravadi RVP, Spigoo DG, Tan WS,et al. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology, 1982, 142:783
4Ho S, Lau WY, Leung TWT,et al. Internal radiation therapy for patients with primary or metastatic hepatic cancer. Cancer, 1998, 83:1894
5Lau WY, Leung WT, Ho S,et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: A phase Ⅰ and Ⅱ sutdy. Br J Cancer, 1994, 70:994
6Ho S, Lau WY, Leung TWT,et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med, 1997, 24:293
7Gray BN, Anderson JE, Burton MA,et al. Regression of liver metastases following treatment with yttrium-90 microspheres. Aust N Z J Surg, 1992, 62:105
8Yan ZP, Lin G, Zhao HY,et al. Anexperimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatrment of primary liver cancer. Cancer, 1993, 72:3210
9Lau WY, Ho S, Leung TWT,et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90Yttrium microspheres. Int J Radiation Oncology Biol Phys, 1998, 40:583
10Burton MA, Gray BN. Adjuvant internal radiatiion therapy in a model of colorectal cancer-dericed hepatic metastases. Br J Cancer, 1995, 71:322
